Randomized phase III trial of adjuvant chemotherapy with gemcitabine vs S-1 in patients with resected pancreatic cancer.
Phase of Trial: Phase III
Latest Information Update: 22 Feb 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 22 Feb 2018 Results (n=354) assessing health-related quality of life with of S-1 versus gemcitabine in patients with pancreatic cancer published in the European Journal of Cancer.
- 02 Jun 2016 Results published in The Lancet.
- 02 Jun 2016 Status changed from active, no longer recruiting to completed, as per an article published in The Lancet.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History